share_log

JMP Securities Maintains Market Outperform on Macrogenics, Lowers Price Target to $8

JMP Securities Maintains Market Outperform on Macrogenics, Lowers Price Target to $8

JMP证券仍然对MacroGenics保持强劲表现,但将价格目标下调至8美元
Benzinga ·  07/31 14:16  · 评级/大行评级

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Market Outperform and lowers the price target from $16 to $8.

JMP证券的分析师Silvan Tuerkcan认为,Macrogenics(纳斯达克:MGNX)的市场表现仍然强劲,并将目标价格从16美元调低至8美元,仍持有买入评级。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发